• 00:00 1.
    index 1
  • 01:28 2.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 05:10 3.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 05:18 4.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 07:09 5.
    CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
  • 11:04 6.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 11:37 7.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 14:21 8.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 16:45 9.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 18:07 10.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 18:12 11.
    CircRNA-SORE was critical for maintaining sorafenib resistance
  • 18:24 12.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 23:17 13.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 27:53 14.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 30:39 15.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 32:43 16.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 33:15 17.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 33:19 18.
    CircRNA-SORE functioned by binding to YBX1 protein
  • 33:56 19.
    Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
  • 42:44 20.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 47:08 21.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 47:58 22.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 50:41 23.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 51:56 24.
    CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
  • 54:44 25.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 59:13 26.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 1:05:11 27.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:05:26 28.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 1:05:28 29.
    ** after 20221121.pptx
  • 1:05:48 30.
    CircRNA-SORE transmited sorafenib resistance by exosomes
  • 1:06:19 31.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:06:21 32.
    ** after 20221121.pptx
  • 1:06:25 33.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:08:31 34.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:08:46 35.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:09:22 36.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:09:30 37.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:09:33 38.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:09:39 39.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:12:00 40.
    Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
  • 1:12:10 41.
    Conclusion
  • 1:16:53 42.
    ** after 20221121.pptx
  • Index
  • Notes
  • Comment
  • Fullscreen
20221121_lab meeting_怡君
Duration: 1:16:56, Browse: 200, Last Updated: 2022-11-21
Attachment(s):
    • 00:00 1.
      index 1
    • 01:28 2.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 05:10 3.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 05:18 4.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 07:09 5.
      CircRNA-SORE was overexpressed in sorafenib-resistant HCC cells
    • 11:04 6.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 11:37 7.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 14:21 8.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 16:45 9.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 18:07 10.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 18:12 11.
      CircRNA-SORE was critical for maintaining sorafenib resistance
    • 18:24 12.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 23:17 13.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 27:53 14.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 30:39 15.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 32:43 16.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 33:15 17.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 33:19 18.
      CircRNA-SORE functioned by binding to YBX1 protein
    • 33:56 19.
      Patients with lower circRNA-SORE or YBX1 expression were associated with better recurrence-free survival
    • 42:44 20.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 47:08 21.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 47:58 22.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 50:41 23.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 51:56 24.
      CircRNA-SORE stabilized YBX1 by preventing its PRP19-mediated degradation
    • 54:44 25.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 59:13 26.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 1:05:11 27.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:05:26 28.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 1:05:28 29.
      ** after 20221121.pptx
    • 1:05:48 30.
      CircRNA-SORE transmited sorafenib resistance by exosomes
    • 1:06:19 31.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:06:21 32.
      ** after 20221121.pptx
    • 1:06:25 33.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:08:31 34.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:08:46 35.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:09:22 36.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:09:30 37.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:09:33 38.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:09:39 39.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:12:00 40.
      Silencing circRNA-SORE substantially improved sorafenib efficacy in vivo
    • 1:12:10 41.
      Conclusion
    • 1:16:53 42.
      ** after 20221121.pptx
    Location
    Folder name
    2022
    Author
    林俐妤
    Branch
    賴亮全教授
    Created
    2022-11-21 10:48:23
    Last Updated
    2022-11-21 11:11:55
    Duration
    1:16:56